Delivery Order SPE2DB24D3013-SPE2DB25FFMPV
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 16, 2025, for the supply of Telmisartan-HCTZ 40-12.5 mg tablets in unit dose packaging (30 count) with a ceiling value of $1,393.00. This is a firm fixed price delivery order with no set-aside designation, competitively awarded under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The contract specifies performance at AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $4,070.31 to AmerisourceBergen Drug Corp for Telmisartan-HCTZ 80-25 mg tablets in unit-dose packaging (30-count), with an ultimate completion date of September 16, 2025. This non-set-aside, competitively awarded contract employs firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (designated SPE2DX), valued at $999,999,999.00 through...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 20, 2025, for the supply of Telmisartan-HCTZ 80-12.5 mg tablets in unit dose packaging (30-count). This is a firm fixed price delivery order with a ceiling value of $2,059.94 and an ultimate completion date of June 23, 2025. The contract is unclassified and was competitively awarded without a set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order on September 9, 2025, valued at $1,227.09 for the supply of Telmisartan-HCTZ 80-12.5 mg tablets in unit dose packages of 30. This is a firm fixed price, competitively awarded delivery order with no set-aside designation, with an ultimate completion date of September 10, 2025. The order will be fulfilled from the vendor's location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $5,750.99 to AmerisourceBergen Drug Corp for the supply of Telmisartan-HCTZ 80-12.5 mg tablets in unit dose packaging (30-count) on August 28, 2025, with an ultimate completion date of August 29, 2025. This competitive award, which utilized firm fixed pricing with no set-aside designation, will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. Telmisartan-HCTZ is a combination...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 31, 2025, for the supply of Telmisartan-HCTZ 80-25 mg tablets in unit dose packaging (30-count), with a ceiling value of $9,953.41. This delivery order is a firm fixed price contract with no set-aside designation, reflecting competitive award status. The contract is scheduled for ultimate completion by August 1, 2025, with performance taking place at AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency awarded a delivery order valued at $29,770.38 to AmerisourceBergen Drug Corp for the supply of Telmisartan-HCTZ 80-12.5 mg tablets in unit dose packaging (30 count) on September 19, 2025, with completion scheduled for September 22, 2025. This delivery order was issued as a firm fixed price contract with no set-aside designation, utilizing open competition. The pharmaceutical product will be delivered to AmerisourceBergen's location in Conshohocken, Pennsylvania,...
- The Defense Logistics Agency awarded a delivery order valued at $3,211.89 to AmerisourceBergen Drug Corp for Telmisartan-HCTZ 40-12.5 mg tablets in unit dose packaging (30-count) on August 28, 2025, with completion targeted for August 29, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be fulfilled from the vendor's location in Conshohocken, Pennsylvania. The contract represents a single transaction under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 12, 2025, for the supply of Telmisartan-HCTZ 80-25 mg tablets in unit dose packaging (30-count). This competitively awarded, non-set-aside contract carries a ceiling value of $4,574.72 and is structured as a firm fixed-price delivery order with an ultimate completion date of August 13, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 16, 2025, for the supply of Telmisartan-HCTZ 40-12.5 mg tablets in unit dose packaging (30-count). This is a firm fixed-price delivery order with a ceiling value of $5,374.94 and an ultimate completion date of June 17, 2025. The award is non-competitive with no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. This delivery order represents a child...
- SPE2DB24D3013Indefinite Delivery Contract
- SPE2DB24D3013-SPE2DB25FFMPVDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 17, 2025, for the supply of Telmisartan-HCTZ 80-12.5 mg tablets in unit dose packaging (30 count) with a ceiling value of $1,215.66. This is a firm fixed price delivery order with no set-aside designation, competitively awarded under open competition. The order is set for ultimate completion by June 18, 2025, with performance to be executed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Telmisartan-HCTZ is a combination antihypertensive medication commonly used within military and federal healthcare systems for blood pressure management. This delivery order is executed under AmerisourceBergen Drug Corp's prime Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, valued at $999,999,999.00 and running through December 2026. This comprehensive pharmaceutical support vehicle enables AmerisourceBergen to supply a broad range of medications, vaccines, and medical supplies to support military healthcare programs globally. As a major pharmaceutical distributor and critical vendor for federal medical procurement, AmerisourceBergen maintains an extensive portfolio of federal contract awards with DLA covering diverse therapeutic domains and product categories across multiple healthcare systems including the Defense Health Agency and U.S. Coast Guard.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.2k | 6/17/25 |